Novo Nordisk NVO has endured a brutal week, with its shares plunging 21% after a series of disappointing clinical results and mounting pricing pressures erased virtually all the gains accumulated since the 2021 approval of its blockbuster obesity therapy, Wegovy (semaglutide)
An intestinal pseudo-obstruction is when a patient appears to have a blockage of the large or small intestine, but in reality, the patients intestinal muscles are not working properly to move food, similar to what was just described for an ileus
Diabetes Care 2006;29:471
Clinical trials show that patients typically regain significant weight after discontinuation
In November 2025 Novo Nordisk filed for submission to the FDA for a higher dose of semaglutide, 7.2mg
Because HIFU works by stimulating your own collagen, visible tightening tends to appear gradually over 8 to 12 weeks, with continued improvement for up to six months